Yang et al. found that IFIT3, a known ISG, can bind to STAT1 and STAT2 and enhance the formation of STAT1-STAT2 heterodimers during IFN-α treatment in HCC, indicating the feedback loop between IFN-I signalling pathway and ISGs [149]. This evidence concerns the gene STAT2 and hepatocellular carcinoma.